Mollie McDermott1, Cemal B Sozener2. 1. University of Michigan Stroke Program, Cardiovascular Center, 3rd Floor, Reception C, 1500 East Medical Center Drive, SPC 5855, Ann Arbor, MI, 48109-5855, USA. mcdermom@med.umich.edu. 2. University of Michigan Stroke Program, Cardiovascular Center, 3rd Floor, Reception C, 1500 East Medical Center Drive, SPC 5855, Ann Arbor, MI, 48109-5855, USA.
Abstract
PURPOSE OF REVIEW: We discuss the evidence and guidelines for acute blood pressure (BP) management for patients presenting with acute ischemic stroke or spontaneous cerebral hemorrhage. RECENT FINDINGS: Observational data suggest that the extremes of BP should be avoided in patients presenting with acute ischemic stroke. There is no convincing evidence that active BP reduction results in improved outcomes for ischemic stroke patients. Current guidelines recommend that BP be maintained ≤ 185/110 mmHg in patients who are candidates for intravenous tissue plasminogen activator (IV tPA) or mechanical thrombectomy and that BP be maintained ≤ 180/105 mmHg for at least 24 h in patients who have received IV tPA or have undergone mechanical thrombectomy. Acute BP goals for spontaneous cerebral hemorrhage remain unclear despite a number of randomized controlled trials. Acute BP goals for patients with acute ischemic stroke largely depend on candidacy for, and receipt of, IV tPA and mechanical thrombectomy. As thrombectomy is now the standard of care for many patients with large vessel occlusion, we will see a heightened interest in pre- and post-thrombectomy BP management. Future trials of spontaneous cerebral hemorrhage may focus on hyperacute BP lowering (e.g., in the prehospital setting).
PURPOSE OF REVIEW: We discuss the evidence and guidelines for acute blood pressure (BP) management for patients presenting with acute ischemic stroke or spontaneous cerebral hemorrhage. RECENT FINDINGS: Observational data suggest that the extremes of BP should be avoided in patients presenting with acute ischemic stroke. There is no convincing evidence that active BP reduction results in improved outcomes for ischemic strokepatients. Current guidelines recommend that BP be maintained ≤ 185/110 mmHg in patients who are candidates for intravenous tissue plasminogen activator (IV tPA) or mechanical thrombectomy and that BP be maintained ≤ 180/105 mmHg for at least 24 h in patients who have received IV tPA or have undergone mechanical thrombectomy. Acute BP goals for spontaneous cerebral hemorrhage remain unclear despite a number of randomized controlled trials. Acute BP goals for patients with acute ischemic stroke largely depend on candidacy for, and receipt of, IV tPA and mechanical thrombectomy. As thrombectomy is now the standard of care for many patients with large vessel occlusion, we will see a heightened interest in pre- and post-thrombectomy BP management. Future trials of spontaneous cerebral hemorrhage may focus on hyperacute BP lowering (e.g., in the prehospital setting).
Authors: Kilian M Treurniet; Olvert A Berkhemer; Rogier V Immink; Hester F Lingsma; Vivian M C Ward-van der Stam; Markus W Hollmann; Jaap Vuyk; Wim H van Zwam; Aad van der Lugt; Robert J van Oostenbrugge; Diederik W J Dippel; Jonathan M Coutinho; Yvo B W E M Roos; Henk A Marquering; Charles B L M Majoie Journal: J Neurointerv Surg Date: 2017-04-12 Impact factor: 5.836
Authors: William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell Journal: Stroke Date: 2018-01-24 Impact factor: 7.914
Authors: J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo Journal: Stroke Date: 2015-05-28 Impact factor: 7.914
Authors: Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan Journal: N Engl J Med Date: 2015-04-17 Impact factor: 91.245
Authors: Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Maxim J H L Mulder; Saliha Ergezen; Hester F Lingsma; Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Geert Lycklama À Nijeholt; Bart J Emmer; H Bart van der Worp; Paul J Nederkoorn; Yvo B W E M Roos; Robert J van Oostenbrugge; Wim H van Zwam; Charles B L M Majoie; Aad van der Lugt; Diederik W J Dippel Journal: Stroke Date: 2017-04-21 Impact factor: 7.914
Authors: Sripal Bangalore; Lee Schwamm; Eric E Smith; Anne S Hellkamp; Robert E Suter; Ying Xian; Phillip J Schulte; Gregg C Fonarow; Deepak L Bhatt Journal: Eur Heart J Date: 2017-10-01 Impact factor: 29.983